Literature DB >> 25054575

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

Julia V Cockle1, Susan V Picton, Alan Melcher.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 25054575      PMCID： PMC6166538          DOI： 10.2217/cns.13.25

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


× No keyword cloud information.
  25 in total

1.  Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma.

Authors:  Adam W Studebaker; Brian Hutzen; Christopher R Pierson; Stephen J Russell; Evanthia Galanis; Corey Raffel
Journal:  Neuro Oncol       Date:  2012-02-03       Impact factor: 12.300

Review 2.  Oncolytic viral therapy of malignant glioma.

Authors:  Jacqueline Nuss Parker; David F Bauer; James J Cody; James M Markert
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

3.  Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.

Authors:  James M Markert; James J Cody; Jacqueline N Parker; Jennifer M Coleman; Kathleen H Price; Earl R Kern; Debra C Quenelle; Alfred D Lakeman; Trenton R Schoeb; Cheryl A Palmer; Samuel C Cartner; G Yancey Gillespie; Richard J Whitley
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

Review 4.  Oncolytic virotherapy reaches adolescence.

Authors:  Adrienne M Hammill; Joseph Conner; Timothy P Cripe
Journal:  Pediatr Blood Cancer       Date:  2010-08-23       Impact factor: 3.167

5.  Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.

Authors:  Xue Qing Lun; Hongyuan Zhou; Tommy Alain; Beichen Sun; Limei Wang; John W Barrett; Marianne M Stanford; Grant McFadden; John Bell; Donna L Senger; Peter A Forsyth
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

Review 6.  Oncolytic viruses: a novel form of immunotherapy.

Authors:  Robin J Prestwich; Kevin J Harrington; Hardev S Pandha; Richard G Vile; Alan A Melcher; Fiona Errington
Journal:  Expert Rev Anticancer Ther       Date:  2008-10       Impact factor: 4.512

7.  Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.

Authors:  Wen Qing Yang; Donna Senger; Huong Muzik; Zhong Qiao Shi; Denise Johnson; Penny M A Brasher; N Barry Rewcastle; Mark Hamilton; Jim Rutka; Johannes Wolff; Cynthia Wetmore; Tom Curran; Patrick W K Lee; Peter A Forsyth
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

Review 8.  Herpes simplex virus oncolytic therapy for pediatric malignancies.

Authors:  Gregory K Friedman; Joseph G Pressey; Alyssa T Reddy; James M Markert; G Yancey Gillespie
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

9.  Effects of G207, a conditionally replication-competent oncolytic herpes simplex virus, on the developing mammalian brain.

Authors:  Andrew E Radbill; Alyssa T Reddy; James M Markert; J Michael Wyss; Martin M Pike; N Shastry Akella; Niteesh Bharara; G Yancey Gillespie
Journal:  J Neurovirol       Date:  2007-04       Impact factor: 2.643

10.  Atypical teratoid rhabdoid tumor: current therapy and future directions.

Authors:  Kevin F Ginn; Amar Gajjar
Journal:  Front Oncol       Date:  2012-09-12       Impact factor: 6.244
View more
  2 in total

1.  Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion.

Authors:  Julia V Cockle; Anke Brüning-Richardson; Karen J Scott; Jill Thompson; Timothy Kottke; Ewan Morrison; Azam Ismail; Angel M Carcaboso; Ailsa Rose; Peter Selby; Joe Conner; Susan Picton; Susan Short; Richard Vile; Alan Melcher; Elizabeth Ilett
Journal:  Mol Ther Oncolytics       Date:  2017-05-02       Impact factor: 7.200

2.  Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies.

Authors:  Ibrahim R Khalil; Martin P Khechara; Sathishkumar Kurusamy; Angel L Armesilla; Abhishek Gupta; Barbara Mendrek; Tamara Khalaf; Mariastella Scandola; Maria Letizia Focarete; Marek Kowalczuk; Iza Radecka
Journal:  Molecules       Date:  2018-10-08       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.